Having depression is not necessarily a contraindication to GLP-1 treatment, but it requires careful discussion with your GP or specialist
What the trials established for the class The evidence base belongs to the compounds
Additionally, this research which included data from tens of thousands of patients, found that the drugs seem to be slightly more effective for women than men
For simplicity, we use the general expression K level in this document
Originally approved for people with type 2 diabetes, several GLP-1 receptor agonists now have FDA indications for weight management, including once-weekly injectable semaglutide 2.4 mg (Wegovy, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly), an injectable GIP/GLP-1 dual incretin-based agonist
Regular follow-up visits and health monitoring ensure you stay on the right path toward maintaining optimal wellness